Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibitionJan A. Burger, Catherine J. Wu, Dan A. Landau et al.|Nature Communications|2016Cited by 346
Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimeticsCameron Fraser, Kristopher A. Sarosiek|Nature Communications|2022Cited by 20
Reciprocal effects of mTOR inhibitors on pro-survival proteins dictate therapeutic responses in tuberous sclerosis complexMolly C. McNamara, Brendan D. Manning, Chin‐Lee Wu et al.|iScience|2022Cited by 5
Dynamic BH3 Profiling Reveals Novel Therapeutic Strategies for the Treatment of Double-Hit LymphomaJennifer L. Crombie, Anthony Letai, Chen Lossos et al.|Blood|2017Cited by 2